Osaic Holdings’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
Other funds holding PBYI
ACA
Osaic Holdings's PBYI Position: Q3 2026 in Review
Osaic Holdings increased its Puma Biotechnology (PBYI) stake by 23% in Q3 2026, buying an estimated $24.4K and bringing the position to 14,936 shares worth $148K. The position accounts for ﹤0.01% of the portfolio, ranked #4675.
Osaic Holdings first reported a position in PBYI in Q1 2020 and has held it in 27 quarters since. The position peaked at $196K in Q3 2021. 156 funds tracked by Wall St. Rank hold PBYI as of Q3 2026.
- Osaic Holdings held 14,936 shares of Puma Biotechnology worth $148K as of Q3 2026.
- Osaic Holdings bought 2,767 Puma Biotechnology shares in Q3 2026, an estimated $24.4K.
- Puma Biotechnology made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #4675 holding.
- Osaic Holdings first reported a position in Puma Biotechnology in Q1 2020 and has held it in 27 quarters since.
- Osaic Holdings's Puma Biotechnology position peaked at $196K in Q3 2021.
- 156 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2026.
Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.